Inari VISION Registry
1 other identifier
observational
1,000
3 countries
10
Brief Summary
This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2025
Longer than P75 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 15, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
March 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2029
May 5, 2026
February 1, 2026
4.8 years
August 15, 2024
May 4, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of device-related, procedure-related, or fatal Adverse Events
Up to 180 days
Interventions
Commercially approved Inari Medical devices
Eligibility Criteria
Patients who have been treated with an Inari Medical device.
You may qualify if:
- Willing and able to provide informed consent per institution and geographical requirements
- Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
- Currently within enrollment window relative to their procedure
- Age ≥ 18 years
You may not qualify if:
- Is or will be inaccessible for registry follow-up
- Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
- Is pregnant or breastfeeding at the time of enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Inari Medicallead
Study Sites (10)
Azienda Ospedaliero Universitaria delle Marche
Ancona, Italy
Santa Marta Hospital
Lisbon, Portugal
Southmead Hospital Bristol
Bristol, United Kingdom
Queen Elizabeth University Hospital
Glasgow, United Kingdom
Northwick Park Hospital
London, United Kingdom
Royal Free Hospital
London, United Kingdom
Royal London
London, United Kingdom
UCLH University College London Hospital
London, United Kingdom
Royal Victoria Infirmary
Newcastle, United Kingdom
Great Western Hospital
Swindon, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 180 Days
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2024
First Posted
September 19, 2024
Study Start
March 7, 2025
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2029
Last Updated
May 5, 2026
Record last verified: 2026-02